Exchange: NASDAQ·Updated 04:13 AM EDT
BGLC logo

BGLCBioNexus Gene Lab Corp

$1.83
$0.02
(1.10%)
Pre-Market
Prev Close $1.81
Mkt Cap$4.38M
Vol311.00
News
all
press releases
News Placeholder
BGLC Stock Tumbled Over 13% Today: Why Is VitaGuard Commercialization Agreement Drawing Investor Attention?
The partnership aims to support the planned commercialization of minimal residual disease testing in Southeast Asia.
Stocktwits
<
...
1
>

Advertisement|Remove ads.